MDL TrackerAntitrust

Class Action

MDL No. 3162  ·  U.S. District Court for the District of Columbia
MDL No.
3162
Docket Type
Antitrust
Transferee Judge
Hon. John D. Bates
Centralized
2025-12-12
Actions Pending
12
As Of
2026-09-01
Funding Considerations

IN RE: Class Action Settlement Administration Litigation was centralized in the District of Columbia in December 2025 and carries 12 pending actions as of the JPML's September 2026 report. The caption itself is atypical for an antitrust MDL — most antitrust dockets name a product, service, or market, while this one names a function (settlement administration) rather than a conventional commodity or platform. Because the JPML's public report identifies the docket type and centralization mechanics but not the underlying complaint, the precise conduct theory driving this consolidation should be confirmed against the actual transfer order before any funding decision is finalized.

What can be said with confidence from the given facts is structural: this is a very early-stage antitrust matter, centralized less than a year before the report date, with a modest and still-developing action count. Early-phase dockets of any kind carry thinner claim files and less pricing certainty than a matter with a developed damages record, and that caution applies with extra force here given the unusual subject matter signaled by the caption.

For a funder, the prudent path on a docket like this is to treat it as a monitoring item rather than an active underwriting target until the underlying complaint and defendant set are verified. Once that verification happens, if the claimant pool turns out to be businesses affected by anticompetitive conduct in a settlement-administration or related commercial market, this would fall under Criterica Capital's commercial litigation finance line like any other antitrust matter. A structure and litigation brief is also available once the underlying theory can be confirmed.

Frequently Asked Questions
What is the underlying dispute in this MDL?
+
Is this docket ready for funding underwriting?
+
What Criterica Capital product would apply once the theory is confirmed?
+
Why flag this docket for review rather than describe it definitively?
+

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.

Litigation structure and resolution-risk brief on Criterica Intelligence →
Holding Class Action claims or inventory?
Send the details and our institutional team will respond within one business day.